![](/img/cover-not-exists.png)
IS RIVAROXABAN ASSOCIATED WITH SHORTER INPATIENT STAYS AND LOWER HOSPITAL COSTS VERSUS HEPARIN/WARFARIN IN LOW-RISK PULMONARY EMBOLISM PATIENTS?
Coleman, Craig I., Weeda, Erin, Peacock, W. Frank, Fermann, Gregory, Crivera, Concetta, Schein, Jeff, Kohn, ChristineVolume:
67
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/s0735-1097(16)32080-0
Date:
April, 2016
File:
PDF, 362 KB
english, 2016